Page last updated: 2024-08-26
hexaphosphamide and Granulocytic Leukemia
hexaphosphamide has been researched along with Granulocytic Leukemia in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Nevskaia, TP | 1 |
Khomchenovskii, EI | 1 |
Trials
1 trial(s) available for hexaphosphamide and Granulocytic Leukemia
Article | Year |
---|---|
[Results of experimental and clinical studies of a new antileukemic drug: hexaphosphamide. Review of the literature and the author's own results].
Topics: Agranulocytosis; Animals; Antineoplastic Agents; Aziridines; Azirines; Clinical Trials as Topic; Drug Resistance; Hematopoiesis; Humans; Lethal Dose 50; Leukemia, Experimental; Leukemia, Myeloid; Neoplasm Transplantation; Organothiophosphorus Compounds; Rats | 1977 |
Other Studies
1 other study(ies) available for hexaphosphamide and Granulocytic Leukemia
Article | Year |
---|---|
[15 years experience in treating chronic myeloleukemia patients at a polyclinic].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Agents; Aziridines; Blood Cell Count; Busulfan; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitobronitol; Organothiophosphorus Compounds; Time Factors | 1984 |